Search research articles
Contact Us
Filters
Showing results (131-140 of 229) with videos related to
Page
of 23
Sort By:
Biochemical and Biophysical Research Communications
|
November 2, 2005
A role for 3-O-sulfotransferase isoform-4 in assisting HSV-1 entry and spread
Vaibhav Tiwari, Christopher D O'Donnell, Myung-Jin Oh, et al.
Journal of Virology
|
August 22, 2014
Comprehensive analysis of herpes simplex virus 1 (HSV-1) entry mediated by zebrafish 3-O-Sulfotransferase isoforms: implications for the development of a zebrafish model of HSV-1 infection
Abraam M Yakoub, Nistha Rawal, Erika Maus, et al.
Investigative Ophthalmology & Visual Science
|
January 19, 2016
Extended Release of an Anti-Heparan Sulfate Peptide From a Contact Lens Suppresses Corneal Herpes Simplex Virus-1 Infection
Dinesh Jaishankar, Jason S Buhrman, Tibor Valyi-Nagy, et al.
Molecular Therapy. Nucleic Acids
|
December 17, 2017
Targeting Herpes Simplex Virus-1 gD by a DNA Aptamer Can Be an Effective New Strategy to Curb Viral Infection
Tejabhiram Yadavalli, Alex Agelidis, Dinesh Jaishankar, et al.
Biomacromolecules
|
April 19, 2007
Viral inhibition studies on sulfated lignin, a chemically modified biopolymer and a potential mimic of heparan sulfate
Arjun Raghuraman, Vaibhav Tiwari, Qian Zhao, et al.
Journal of Virology
|
July 27, 2018
Herpes Simplex Virus 1 Infection Promotes the Growth of a Subpopulation of Tumor Cells in Three-Dimensional Uveal Melanoma Cultures
Tibor Valyi-Nagy, Brian Fredericks, Aditya Ravindra, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
February 4, 2026
Host-directed novel mechanistic insights of doxorubicin reveal its efficacy against drug-resistant HSV-1 underscoring risks with oncolytic virotherapy
Pankaj Sharma, Divya Kapoor, Sudhanshu Kumar Singh, et al.
Journal of Clinical Medicine
|
June 21, 2020
Vaccines and Therapies in Development for SARS-CoV-2 Infections
David Wu, Raghuram Koganti, Upendra P Lambe, et al.
Antiviral Research
|
October 11, 2012
Prophylactic, therapeutic and neutralizing effects of zinc oxide tetrapod structures against herpes simplex virus type-2 infection
Thessicar E Antoine, Yogendra K Mishra, James Trigilio, et al.
Investigative Ophthalmology & Visual Science
|
August 31, 2013
An investigative peptide-acyclovir combination to control herpes simplex virus type 1 ocular infection
Paul J Park, Thessicar E Antoine, Asim V Farooq, et al.
Page
of 23
Search research articles
Search
Showing results (131-140 of 229) with videos related to
Sort By:
Page
of 23
Biochemical and Biophysical Research Communications
|
November 2, 2005
A role for 3-O-sulfotransferase isoform-4 in assisting HSV-1 entry and spread
Vaibhav Tiwari, Christopher D O'Donnell, Myung-Jin Oh, et al.
Journal of Virology
|
August 22, 2014
Comprehensive analysis of herpes simplex virus 1 (HSV-1) entry mediated by zebrafish 3-O-Sulfotransferase isoforms: implications for the development of a zebrafish model of HSV-1 infection
Abraam M Yakoub, Nistha Rawal, Erika Maus, et al.
Investigative Ophthalmology & Visual Science
|
January 19, 2016
Extended Release of an Anti-Heparan Sulfate Peptide From a Contact Lens Suppresses Corneal Herpes Simplex Virus-1 Infection
Dinesh Jaishankar, Jason S Buhrman, Tibor Valyi-Nagy, et al.
Molecular Therapy. Nucleic Acids
|
December 17, 2017
Targeting Herpes Simplex Virus-1 gD by a DNA Aptamer Can Be an Effective New Strategy to Curb Viral Infection
Tejabhiram Yadavalli, Alex Agelidis, Dinesh Jaishankar, et al.
Biomacromolecules
|
April 19, 2007
Viral inhibition studies on sulfated lignin, a chemically modified biopolymer and a potential mimic of heparan sulfate
Arjun Raghuraman, Vaibhav Tiwari, Qian Zhao, et al.
Journal of Virology
|
July 27, 2018
Herpes Simplex Virus 1 Infection Promotes the Growth of a Subpopulation of Tumor Cells in Three-Dimensional Uveal Melanoma Cultures
Tibor Valyi-Nagy, Brian Fredericks, Aditya Ravindra, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
February 4, 2026
Host-directed novel mechanistic insights of doxorubicin reveal its efficacy against drug-resistant HSV-1 underscoring risks with oncolytic virotherapy
Pankaj Sharma, Divya Kapoor, Sudhanshu Kumar Singh, et al.
Journal of Clinical Medicine
|
June 21, 2020
Vaccines and Therapies in Development for SARS-CoV-2 Infections
David Wu, Raghuram Koganti, Upendra P Lambe, et al.
Antiviral Research
|
October 11, 2012
Prophylactic, therapeutic and neutralizing effects of zinc oxide tetrapod structures against herpes simplex virus type-2 infection
Thessicar E Antoine, Yogendra K Mishra, James Trigilio, et al.
Investigative Ophthalmology & Visual Science
|
August 31, 2013
An investigative peptide-acyclovir combination to control herpes simplex virus type 1 ocular infection
Paul J Park, Thessicar E Antoine, Asim V Farooq, et al.
Page
of 23